162 related articles for article (PubMed ID: 1687206)
1. Taxol: a new and effective anti-cancer drug.
Slichenmyer WJ; Von Hoff DD
Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206
[TBL] [Abstract][Full Text] [Related]
2. Taxol: an important new drug in the management of epithelial ovarian cancer.
Markman M
Yale J Biol Med; 1991; 64(6):583-90. PubMed ID: 1687343
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Rowinsky EK; Burke PJ; Karp JE; Tucker RW; Ettinger DS; Donehower RC
Cancer Res; 1989 Aug; 49(16):4640-7. PubMed ID: 2568175
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological action of paclitaxel].
Potemski P; Płuzańska A
Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of taxol given as a 3-hour infusion every 21 days.
Kris MG; O'Connell JP; Gralla RJ; Wertheim MS; Parente RM; Schiff PB; Young CW
Cancer Treat Rep; 1986 May; 70(5):605-7. PubMed ID: 2871928
[TBL] [Abstract][Full Text] [Related]
6. [Paclitaxel (Taxol)].
Hájek R
Cas Lek Cesk; 1996 Jun; 135(12):393-6. PubMed ID: 8706079
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of taxol in patients with advanced cancer.
Donehower RC; Rowinsky EK; Grochow LB; Longnecker SM; Ettinger DS
Cancer Treat Rep; 1987 Dec; 71(12):1171-7. PubMed ID: 2891441
[TBL] [Abstract][Full Text] [Related]
8. New natural products in cancer chemotherapy.
Slichenmyer WJ; Von Hoff DD
J Clin Pharmacol; 1990 Sep; 30(9):770-88. PubMed ID: 1980498
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel: a new antimitotic chemotherapeutic agent.
Gotaskie GE; Andreassi BF
Cancer Pract; 1994; 2(1):27-33. PubMed ID: 7914453
[TBL] [Abstract][Full Text] [Related]
10. Taxol: a novel investigational antimicrotubule agent.
Rowinsky EK; Cazenave LA; Donehower RC
J Natl Cancer Inst; 1990 Aug; 82(15):1247-59. PubMed ID: 1973737
[TBL] [Abstract][Full Text] [Related]
11. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
Yamazaki S; Sekine I; Saijo N
Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
[TBL] [Abstract][Full Text] [Related]
12. [Taxol and ovarian adenocarcinomas].
Marty M; Extra JM; Culine S; Rousseau F
Pathol Biol (Paris); 1992 Nov; 39(9):834-5. PubMed ID: 1347165
[No Abstract] [Full Text] [Related]
13. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer.
Gregory RE; DeLisa AF
Clin Pharm; 1993 Jun; 12(6):401-15. PubMed ID: 7691462
[TBL] [Abstract][Full Text] [Related]
14. [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes].
Chazard M; Pellae-Cosset B; Garet F; Soares JA; Lucidi B; Lavail Y; Lenaz L
Bull Cancer; 1994 Mar; 81(3):173-81. PubMed ID: 7894125
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of taxol administered as a short i.v. infusion daily for 5 days.
Grem JL; Tutsch KD; Simon KJ; Alberti DB; Willson JK; Tormey DC; Swaminathan S; Trump DL
Cancer Treat Rep; 1987 Dec; 71(12):1179-84. PubMed ID: 2891442
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
17. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
Mayerhofer K; Kucera E; Zeisler H; Speiser P; Reinthaller A; Sevelda P
Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
[TBL] [Abstract][Full Text] [Related]
18. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
[TBL] [Abstract][Full Text] [Related]
19. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
McGuire WP; Rowinsky EK; Rosenshein NB; Grumbine FC; Ettinger DS; Armstrong DK; Donehower RC
Ann Intern Med; 1989 Aug; 111(4):273-9. PubMed ID: 2569287
[TBL] [Abstract][Full Text] [Related]
20. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
